What is the most funded medical research?

  1. Røttingen J-A, Regmi S, Eide M, Young AJ, Viergever RF, Årdal C, et al. Mapping available health R&D data: what’s there, what’s missing and what role for a Global Observatory. Lancet. 2013;382:1286–307.

    Article  PubMed  Google Scholar 

  2. Viergever RF. The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions. Glob Health Action. 2013;6:22450.

    PubMed  Google Scholar 

  3. Power E. Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect. 2006;12 Suppl 5:25–34.

    Article  PubMed  Google Scholar 

  4. Spellberg B, Bartlett JG, Gilbert DN. The future of antibiotics and resistance. N Engl J Med. 2013;368:299–302.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. Head MG, Fitchett JR, Cooke MK, Wurie FB, Atun R, Hayward AC, et al. Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997–2010. J Antimicrob Chemother. 2014;69:548–54.

    CAS  Article  PubMed  Google Scholar 

  6. Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156–65.

    Article  PubMed  Google Scholar 

  7. Sampat BN, Buterbaugh K, Perl M. New evidence on the allocation of NIH funds across diseases. Milbank Q. 2013;91:163–85.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Terry RF, Allen L, Gardner C, Guzman J, Moran M, Viergever RF. Mapping global health research investments, time for new thinking – A Babel Fish for research data. Health Res Policy Syst. 2012;10:28.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Viergever RF. Aid alignment for global health research: the role of HIROs. Health Res Policy Syst. 2011;9:12.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Couzin-Frankel J. Chasing the money. Science. 2014;344:24–5.

    CAS  Article  PubMed  Google Scholar 

  11. Track and trace. Nature. 2014;507:8.

  12. World Health Summit. Workshop: global health research & development: mapping funding flows – working towards a common approach. Geneva: WHO; 2014.

    Google Scholar 

  13. Gillum LA, Gouveia C, Dorsey ER, Pletcher M, Mathers CD, McCulloch CE, et al. NIH disease funding levels and burden of disease. PLoS One. 2011;6:e16837.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  14. What has the Gates Foundation done for global health? Lancet. 2009;373:1577.

  15. Matthews KR, Ho V. The grand impact of the Gates Foundation. Sixty billion dollars and one famous person can affect the spending and research focus of public agencies. EMBO Rep. 2008;9:409–12.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  16. World Health Organization. WHO informal workshop – monitoring financial flows in support of health research & development. Geneva: WHO; 2013.

    Google Scholar 

  17. Young AJ, Terry RF, Røttingen J-A, Viergever RF. Global biomedical R&D expenditures. N Engl J Med. 2014;370:2451.

    CAS  Article  PubMed  Google Scholar 

  18. Chakma J, Sun GH, Steinberg JD, Sammut SM, Jagsi R. Asia’s ascent--global trends in biomedical R&D expenditures. N Engl J Med. 2014;370:3–6.

    CAS  Article  PubMed  Google Scholar 

  19. Sun GH, Steinberg JD, Jagsi R. The calculus of national medical research policy--the United States versus Asia. N Engl J Med. 2012;367:687–90.

    CAS  Article  PubMed  Google Scholar 

  20. Young AJ, Terry RF, Røttingen J-A, Viergever RF. Global trends in health research and development R&D expenditures – the challenge of making reliable estimates for international comparison. Health Res Policy Syst. 2015;13.

  21. Myers ER, Alciati MH, Ahlport KN, Sung NS. Similarities and differences in philanthropic and federal support for medical research in the United States: an analysis of funding by nonprofits in 2006–2008. Acad Med. 2012;87:1574–81.

    Article  PubMed  Google Scholar 

  22. Reports & Downloads: Health Research Analysis Data. http://www.hrcsonline.net/pages/data. Accessed 13 January 2016.

  23. Braun D. Structure and dynamics of health research and public funding: an international institutional comparison. Dordrecht: Kluwer Academic Publishers; 1994.

    Google Scholar 

  24. UK Clinical Research Collaboration. UK health research analysis 2009/2010. London: UKCRC; 2010.

    Google Scholar 

  25. Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Atun R. UK investments in global infectious disease research 1997–2010: a case study. Lancet Infect Dis. 2013;2013(13):55–64.

    Article  Google Scholar 

  26. Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, White-Stellato Z, et al. Funding of US biomedical research, 2003–2008. JAMA. 2010;303:137–43.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. Moran M, Guzman J, Henderson K, Liyanage R, Wu L, Chin E, et al. G-FINDER 2012 – neglected disease research & development: a five year review. Sydney: Policy Cures; 2012.

    Google Scholar 

  28. Frick M, Jiménez-Levi E. Tuberculosis Research and Development. Report on tuberculosis research funding trends, 2005–2012. New York: Treatment Action Group; 2013.

  29. Head MG, Fitchett JR, Cooke GS, Foster GR, Atun R. Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom. J Viral Hepat. 2015;22(3):230–7. doi:10.1111/jvh.12300.

    CAS  Article  PubMed  Google Scholar 

  30. The EU Industrial R&D Investment Scoreboard. http://iri.jrc.ec.europa.eu/scoreboard.html. Accessed 13 January 2016.

  31. Saving Lives through Research: Annual Report and Accounts 2012/13. London: Cancer Research UK; 2013.

  32. Research Facts 2012–13. American Heart Association; 2014. https://my.americanheart.org/idc/groups/ahamahpublic/@wcm/@sop/@rsch/documents/downloadable/ucm_317600.pdf. Accessed 13 January 2016.

  33. International Monetary Fund (IMF) World Economic Outlook Database. https://www.imf.org/external/pubs/ft/weo/2014/01/weodata/index.aspx. Accessed 13 January 2016.

  34. World Health Organization: Global Health Estimates. http://www.who.int/healthinfo/global_burden_disease/en/. Accessed 13 January 2016.

  35. Frenk J. The new public health. Annu Rev Public Health. 1993;14:469–90.

    CAS  Article  PubMed  Google Scholar 

  36. Kaiser J. Funding. NIH institute considers broad shift to “people” awards. Science. 2014;345:366–7.

    CAS  Article  PubMed  Google Scholar 

  37. Callahan D. Shaping biomedical research priorities: the case of the National Institutes of Health. Health Care Anal. 1999;7:115–29.

    CAS  Article  PubMed  Google Scholar 

  38. Ioannidis JPA. More time for research: fund people not projects. Nature. 2011;477:529–31.

    CAS  Article  PubMed  Google Scholar 

  39. Research funding needs overhaul. Science (80-) 2014, 345:122.

  40. Banzi R, Moja L, Pistotti V, Facchini A, Liberati A. Conceptual frameworks and empirical approaches used to assess the impact of health research: an overview of reviews. Health Res Policy Syst. 2011;9:26.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Lal B, Wilson A, Jonas S, Lee E, Richards A, Peña V. An outcome evaluation of the national institutes of health (NIH) Director’s pioneer award (NDPA) program, FY 2004–2006. Washington: Ida Science & Technology Policy Institute; 2012.

    Google Scholar 

  42. Collins FS, Wilder EL, Zerhouni E. NIH roadmap/common fund at 10 years. Science. 2014;345:274–6.

    CAS  Article  PubMed  Google Scholar 

  43. Azoulay P, Graff Zivin JS, Manso G. Incentives and creativity: evidence from the academic life sciences. RAND J Econ. 2011;42:527–54.

    Article  Google Scholar 

  44. Viergever RF, Olifson S, Ghaffar A, Terry RF. A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst. 2010;8:36.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Hegde D, Sampat BN. Can private money buy public science? Disease group lobbying and federal funding for biomedical research. https://www8.gsb.columbia.edu/faculty-research/sites/faculty-research/files/canprivate.pdf. Accessed 13 January 2016.

  46. Reardon S. Lobbying sways NIH grants. Nature. 2014;515:19.

    CAS  Article  PubMed  Google Scholar 

  47. Viergever RF, Hendriks TCC. Targeted public funding for health research in the Netherlands. Ned Tijdschr Geneeskd. 2014;159:A8174.

    PubMed  Google Scholar 

  48. Collins F, Beaudet A, Draghia-Akli R, Gruss P, Savill J, Syrota A, et al. A database on global health research in Africa. Lancet Glob Heal. 2013;1:e64–5.

    Article  Google Scholar 

  49. Rani M, Bekedam H, Buckley BS. Improving health research governance and management in the Western Pacific: a WHO expert consultation. J Evid Based Med. 2011;4:204–13.

    Article  PubMed  Google Scholar 

  50. Research classification in practice: Stamping or Understanding! http://www.uberresearch.com/uberresWP/wp-content/uploads/CASRAI-ReConnect-Research-Classification-2-UberResearch_March-2014.pdf. Accessed 13 January 2016.

  51. Erawatch: Platform on Research and Innovation policies and systems. http://erawatch.jrc.ec.europa.eu/. Accessed 15 August 2014.

  52. The National Institute of Allergy and Infectious Diseases (NIAID): Choose Approach and Find FOAs. http://www.niaid.nih.gov/researchfunding/grant/strategy/pages/2choosefoa.aspx. Accessed 13 January 2016.

  53. Wilkinson E. Wellcome Trust overhauls its funding framework. Lancet. 2014;384:1913.

    Article  PubMed  Google Scholar 

  54. G-FINDER public search tool. http://g-finder.policycures.org/gfinder_report/. Accessed 13 January 2016.

  55. Terry RF, van der Rijt T. Overview of research activities associated with the World Health Organization: results of a survey covering 2006/07. Health Res Policy Syst. 2010;8:25.

    Article  PubMed  PubMed Central  Google Scholar 


Page 2

# Public and philanthropic health research funding organizations Country Type of funding organization Year for which funding data were collected Total health research expenditures (in million 2013 US $) Specificity of the funding dataa Research area that the funding data refer toa Reporting format of the funding dataa
1 National Institutes of Health (NIH) USA Public 2013 26,081.3 I A 1
2 European Commission (EC)b EU Public 2013 3717.7 II A 1
  2a FP7 - Cooperation programme - Health Theme/Health Directorate c EU Public 2013 1181.7 II A 1
  2b European Research Council (ERC) EU Public 2013 783.4 II A 1
3 UK Medical Research Council (MRC) GBR Public 2013 1321.5 I A 1
4 Institut national de la santé et de la recherche médicale (Inserm) FRA Public 2013 1041.2 I A 1
5 United States Department of Defense (US DoD)b USA Public 2013 1017.7 I A 2
  5a Congressionally Directed Medical Research Program (CDMRP) USA Public 2012 409.0 I A 1
6 Wellcome Trustd GBR Philanthropic 2013 909.1 I A 1
7 Canadian Institutes of Health Research (CIHR) CAN Public 2012 883.6 I A 1
8 Australian National Health and Medical Research Council (NHMRC) AUS Public 2013 777.6 I A 1
9 Howard Hughes Medical Institute (HHMI) USA Philanthropic 2013 752.0 I A 1
10 Deutsche Forschungsgemeinschaft / German Research Foundation (DFG) DEU Public 2012 630.6 I A 1
11 National Natural Science Foundation of China (NSFC) CHN Public 2012 621.3 II A 1
12 Centre National de la Recherche Scientifique (CNRS) FRA Public 2013 531.0 III B 2
13 UK Department of Health / National Institute for Health Research (NIHR) GBR Public 2012 491.2 I A 1
14 Japan Society for Promotion of Science (JSPS) JPN Public 2011 472.5 I A 1
15 Bundesministerium für Bildung und Forschung / Federal Ministry of Education and Research of Germany (BMBF) DEU Public 2013 472.1 I A 1
16 Bill & Melinda Gates Foundation (BMGF)e USA Philanthropic 2011 462.6 I A 1
17 Ministero della Salute / Ministry of Health of Italy ITA Public 2007 438.6 I A 2
18 Instituto de Salud Carlos III (ISCIII)e ESP Public 2011 388.2 I A 1
19 Ministry of Health of China CHN Public 2011 371.7 I A 1
20 Japan Science and Technology Agency (JST)e JPN Public 2012 338.5 I C 2
21 Institut Pasteur FRA Philanthropic 2013 220.9 I A 1
22 Singapore National Medical Research Council (NMRC) SGP Public 2012 220.7 A 1
23 Korean National Research Foundation (NRF) KOR Public 2011 191.5 I A 1
24 Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)e ARG Public 2012 184.4 II B 1
25 Vetenskapsrådet-Medicine / Swedish Research Council SWE Public 2012 177.9 A 1
26 Swiss National Science Foundation (SNSF) CHE Public 2012 172.9 I A 1
27 ZonMw / Netherlands Organisation for Health Research and Development NLD Public 2012 172.7 I A 1
28 Sao Paulo Research Foundation (FAPESP)e BRA Public 2012 154.2 I A 1
29 Indian Council of Medical Research (ICMR) IND Public 2011 140.3 I A 3
30 Fund for Scientific Research - Flanders (FWO) BEL Public 2010 136.9 I A 1
31 Korea National Institute of Health (KNIH) KOR Public 2013 120.0 III A 2
32 Forskingsrådet / Research Council of Norway NOR Public 2012 113.5 III A 2
33 Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) BRA Public 2013 110.8 I A 2
34 Fonds zur Förderung der wissenschaftlichen Forschung / Austrian Science Fund (FWF) AUT Public 2012 99.5 I C 1
35 South African Medical Research Council (SA MRC) ZAF Public 2012 63.2 I A 3
36 Health Research Council of New Zealand NZL Public 2012 61.6 III A 1
37 Danish Council for Independent Research / Medical Sciences DNK Public 2012 58.5 II A 1
38 Russian Foundation for Basic Research (RFBR) RUS Public 2013 53.6 III B 2
39 Danish Council for Strategic Research (two programmes: Individuals, Disease and Society & Health, Food and Welfare) DNK Public 2012 40.3 II C 1
40 Consejo Nacional de Ciencia y Tecnología (CONACYT) MEX Public 2010 21.9 II A 2
41 South African Department of Science and Technology (DST) ZAF Public 2012 13.5 I B 1
42 Agencia Nacional de Promocion Cientifica y Technologica (Agenica - ANPCyT) ARG Public No data
43 Biomedical Research Council of the Singapore Agency for Science, Technology and Research (BMRC of A*STAR) SGP Public No data
44 Ministry of Science and Technology of China (MOST) CHN Public No data
45 Indian Department of Biotechnology (DBT) IND Public No data
46 Indian Department of Science and Technology (DST) IND Public No data
47 King Abdulaziz City for Science and Technology (KACST) SAU Public No data
48 Le Fonds de la Recherche Scientifique (FNRS) BEL Public No data
49 Lipi Indonesian Research Council IDN Public No data
50 Ministry of Healthcare of the Russian Federation RUS Public No data
51 National Research Foundation South Africa (NRF SA) ZAF Public No data
52 Oswaldo Cruz Foundation (Fiocruz) BRA Philanthropic No data
53 Rockefeller foundation USA Philanthropic No data
54 Tubitak / Scientific and Technological Research Council of Turkey TUR Public No data
55 Turkish Academy of Sciences (TUBA) TUR Public No data
  Total for the 10 largest funders of health research     37,132.2    
  Total for funders 11 to 41     7116.2    
  Total for all 41 funding organizations for which data were available     44,248.3    

  1. Dashes (“–”) indicate that no information was available. Funders of Official Development Assistance (ODA) and multilaterals funders are excluded from this table and are reported separately. Data presented in the table are from the most recent year available at the time of data collection. Reported expenditures on health research can differ from what funders themselves report, because we excluded operational costs for managing the funding organization where possible, and because we excluded funding for research education
  2. aFunders report differently on their expenditures. Preferably, we collected information on the actual expenditures of a funder in the area of health research, excluding funders’ operational costs. However, this information was not always available. Therefore, we describe here the type of data that we collected, in terms of how funding organizations report annual health research expenditures (i.e. I, actual expenditures; II, commitments; or III, budgets), in terms of the research areas that their reported numbers pertain to (i.e. A, only health research; B, health and biological research; or C, life sciences research), and in terms of what the expenditures cover (i.e. 1, total expenditures on health research excluding operational costs; 2, total expenditures on health research including also operational costs; or 3, total overall turnover for the funder over a single fiscal year)
  3. bTwo funders consisted of several sub-programmes with very different funding distribution mechanisms and patterns. (1) For the European Commission: Under the EC the FP7 was the largest research program in FY 2007–2013. The ERC and Cooperation programme - Health theme (the Health Directorate is the executive agency for the latter) are both programmes run under FP7. Under the FP7 there are several funding programmes: Ideas – ERC, Cooperation programme, People – Marie Curie, Capacity Program, CIP and Euratom. Due to this large number of funding programmes, and the differences between the funding programmes, we reviewed the two largest funding programmes: the Cooperation – Health theme and the Ideas – ERC programme. (2) For the US DoD: The defence health program holds 14 research programmes. We chose to review the largest programme, which was identified as the CDMRP
  4. cThe ERC was able to provide figures for its funding distribution mechanisms in the area of Life Sciences, not of health research. However, the website www.healthcompetence.eu provided figures of health research funding by the ERC. For consistency, figures for the Health theme of the FP7 Cooperation programme were extracted from the same website. There are slight deviations between these figures and the health research spending reported by FP7 Cooperation programme itself
  5. dThe annual expenditures for the Wellcome Trust are a slight overestimation for health research spending. Under Medical Humanities and engagement, various non-research grants are provided as well as other activities (e.g. running the Wellcome library), but these were not reported on separately, and are therefore included under ‘Research’
  6. eInformation was collected from official websites and annual reports. For these five organizations, information was not publicly available, and was acquired through personal communication with a representative of the organization